Skip to main content

Cancer Research Legislation

This page provides summaries of legislation proposed in the 116th Congress specific to particular diseases, as well as other topics such as childhood cancer and cancer survivorship. This page will be updated as relevant legislation is introduced.

Triple-Negative Breast Cancer Research and Education Act of 2019 (H.R. 5939)

  • The legislation was introduced by Rep. Sheila Jackson Lee (D-TX) on 2/21/20. The bill was referred to the Committee on Energy & Commerce.
  • The legislation would authorize funds for NIH to expand, intensify, and coordinate programs for the conduct and support of research with respect to triple-negative breast cancer.

The Endometrial Cancer Research and Education Act (H.R. 5794)

  • The legislation was introduced by Rep. David Scott (D-GA) on 2/6/20. The bill was referred to the Committee on Energy & Commerce. 
  • The legislation would authorize $500,000 annually from fiscal years 2021 through 2023 to support research at the NIH on endometrial cancer. This bill would also create an Endometrial Cancer Public Education Program at the Centers for Disease Control and Prevention.

Fairness to Kids with Cancer Act of 2019 (H.R. 4429)

  • This legislation was introduced by Rep. Brian Fitzpatrick (R-PA) on 9/20/19. The bill was referred to the Committee on Energy & Commerce.
  • The legislation would adjust the level of federal investment in pediatric cancer research to match the percentage of American citizens under the age of 18, based on U.S. Census data.

Women and Lung Cancer Research and Preventive Services Act of 2019 (H.R. 2222, S. 1107)

  • The legislation was introduced on 4/10/19 by Rep. Brendan Boyle (D-PA) in the House and Sen. Marco Rubio (R-FL) in the Senate. The House bill was referred to the Committee on Energy & Commerce and the Senate bill was referred to the Committee on Health, Education, Labor, and Pensions.
  • The bills would encourage more research into the prevention and treatment of lung cancer in women, particularly for those who have never smoked, and would require federal agencies to evaluate and report their findings to Congress.

Henrietta Lacks Enhancing Cancer Research Act of 2019 (H.R. 1966, S. 946)

  • The legislation was introduced on 3/28/19 by Rep. Elijah Cummings (D-MD) in the House and Sen. Chris Van Hollen (D-MD) in the Senate. The House bill was referred to the Committee on Energy & Commerce the Senate bill was referred to the Committee on Health, Education, Labor, and Pensions.
  • The bill calls for the Government Accountability Office (GAO) to complete a study that reviews actions taken by federal agencies to help to address barriers to participation in federally funded cancer clinical trials by populations that have been traditionally underrepresented in such trials. The legislation also instructs the GAO to identify additional actions that can be taken by federal agencies to address these barriers and to submit a report to Congress on the results of the study, including the GAO recommendations.
  • The legislation notes that the study should include review of cancer clinical trials that are largely funded by Federal agencies, including the NIH.
  • Updated: